Cargando…

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?

OBJECTIVES: Overactive bladder (OAB) symptoms are often encountered in patients after transurethral resection of the prostate (TUR-P) or transurethral incision of the prostate (TUI-P) for benign prostatic obstruction (BPO). Either antimuscarinics or β-3 agonist has been found effective in relieving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Cheng-Ling, Kuo, Hann-Chorng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683516/ https://www.ncbi.nlm.nih.gov/pubmed/38035054 http://dx.doi.org/10.4103/tcmj.tcmj_123_23

Ejemplares similares

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
por: Chuang, Fei-Chi, et al.
Publicado: (2018)

Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia
por: Lee, Cheng-Ling, et al.
Publicado: (2017)

Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasia
por: Liao, Chun-Hou, et al.
Publicado: (2017)

Tamsulosin and Solifenacin in the Treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
por: Wang, Hui, et al.
Publicado: (2017)

Precision medicine in the diagnosis and treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia
por: Chen, Jing-Liang, et al.
Publicado: (2019)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
por: Allameh, Farzad, et al.
Publicado: (2020)

How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies
por: Kuo, Hann-Chorng
Publicado: (2020)

Transurethral Resection of Prostate Abscess: Is It Different from Conventional Transurethral Resection for Benign Prostatic Hyperplasia?
por: Goyal, Neeraj Kumar, et al.
Publicado: (2013)

Transurethral ethanol ablation for symptomatic benign prostatic hyperplasia
por: Gautam, Gagan, et al.
Publicado: (2007)

Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia
por: El-Tabey, Magdy, et al.
Publicado: (2015)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
por: Oka, Anak Agung Gde, et al.
Publicado: (2019)

Individualizing medical treatment of overactive bladder
por: Kuo, Hann-Chorng
Publicado: (2018)

Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts
por: Lee, Cheng-Ling, et al.
Publicado: (2017)

Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
por: Zhou, Jing, et al.
Publicado: (2022)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
por: Radwan, Ahmed, et al.
Publicado: (2020)

Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
por: Chiang, Bing-Juin, et al.
Publicado: (2019)

Modified bladder outlet obstruction index for powerful efficacy prediction of transurethral resection of prostate with benign prostatic hyperplasia
por: Liu, Hongming, et al.
Publicado: (2021)

The Effect of Transurethral Resection of the Prostate on Erectile Function in Patients with Benign Prostatic Hyperplasia
por: Choi, Seong Beom, et al.
Publicado: (2010)

A multicenter retrospective study of transurethral prostate split for benign prostate hyperplasia
por: Wei, Jingchao, et al.
Publicado: (2022)

AB067. Transurethral endoscopic treatment of benign prostatic hyperplasia
por: Meng, Qingjun, et al.
Publicado: (2017)

Increased Serum C-Reactive Protein Level Is Associated with Increased Storage Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia
por: Hung, Shun-Fa, et al.
Publicado: (2014)

AB016. Transurethral PlasmaKinetic enucleation of prostate versus transurethral PlasmaKinetic resection of prostate for benign prostate hyperplasia
por: Sun, Ting, et al.
Publicado: (2016)

Effect of Transurethral Resection of the Prostate on Storage Symptoms in Patients with Benign Prostatic Hyperplasia of Less than 30 ml
por: Kang, Yu Jin, et al.
Publicado: (2013)

Bladder Neck Contracture after Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia Treated with a Thermo-Expandable Metal Stent (Memokath® 045)
por: Wen, Jan, et al.
Publicado: (2018)

Long-Term Followup after Electrocautery Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
por: Kallenberg, F., et al.
Publicado: (2011)

AB001. Transurethral balloon dilatation of prostate in treatment of patients with benign prostatic hyperplasia
por: Guo, Yinglu
Publicado: (2015)

Transurethral enucleation of prostate with button electrode plasmakinetic vaporization for the treatment of Benign Prostatic Hyperplasia
por: Peng, Bo, et al.
Publicado: (2016)

Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis
por: Huang, Yiyu, et al.
Publicado: (2020)

Transurethral Microwave Thermotherapy for Benign Prostatic Hyperplasia: An Updated Cochrane Review
por: Franco, Juan Victor Ariel, et al.
Publicado: (2022)

Oncological safety of simultaneous transurethral resection of high-grade urothelial carcinoma of the bladder and benign prostatic hyperplasia
por: Sionov, Ben Valery, et al.
Publicado: (2022)

Selective Transurethral Resection of the Prostate Combined with Transurethral Incision of the Bladder Neck for Bladder Outlet Obstruction in Patients with Small Volume Benign Prostate Hyperplasia (BPH): A Prospective Randomized Study
por: Li, Xin, et al.
Publicado: (2013)

Transurethral balloon dilatation of the Prostate and Transurethral Plasmakinetic resection of the Prostate in the treatment of Prostatic Hyperplasia
por: Chang, Yanhua, et al.
Publicado: (2018)

Surgical management of benign prostate hyperplasia in Nigeria: open prostatectomy versus transurethral resection of the prostate
por: Ofoha, Chimaobi Gideon, et al.
Publicado: (2021)

Combination of transurethral resection of the prostate and flexible and rigid ureteroscopy for benign prostatic hyperplasia and ureteral calculus
por: He, Kunlun, et al.
Publicado: (2021)

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)
por: Zeng, Xian-Tao, et al.
Publicado: (2022)

Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis
por: Jiang, Yu-Li, et al.
Publicado: (2019)

Contemporary Outcomes after Transurethral Procedures for Bladder Neck Contracture Following Endoscopic Treatment of Benign Prostatic Hyperplasia
por: Rosenbaum, Clemens M., et al.
Publicado: (2021)

Long-term Combination Therapy With α-Blockers and 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia: Patient Adherence and Causes of Withdrawal From Medication
por: Ong, Hueih Ling, et al.
Publicado: (2016)

Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study
por: Kwon, Se Yun, et al.
Publicado: (2020)

Comparison between a transurethral prostate split and transurethral prostate resection for benign prostatic hyperplasia treatment in a small prostate volume: a prospective controlled study
por: Wang, Bohan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n5pjsr13sv0i3aapsegh8knumq